Results 171 to 180 of about 15,380 (223)

Predicting prognosis and optimal timing for surgery using CA 19-9 in patients with pancreatic cancer who underwent FOLFIRINOX-based neoadjuvant therapy: a retrospective single-center cohort study. [PDF]

Ann Surg Treat Res
Chae H, Kim HS, Yoon SJ, Shin SH, Han IW, Heo JS, Kim H.   +6 more
europepmc   +1 more source

EASIX Score as an Independent Prognostic Marker in De Novo Metastatic Pancreatic Cancer. [PDF]

Medicina (Kaunas)
Çıtakkul İ, Temi YB, Aytin Z, Baydar E, Kefeli U, Çabuk D, Uygun K.   +6 more
europepmc   +1 more source

Investigating survival patterns in pancreatic adenocarcinoma over two decades after introducing FOLFIRINOX. [PDF]

J Gastrointest Oncol
Döbereiner J, Kleeff J, Rebelo A.
europepmc   +1 more source

An uncommon multimodal management approach for low-grade appendiceal mucinous neoplasm with pseudomyxoma peritonei and mucinous borderline ovarian tumor. [PDF]

Ann Med Surg (Lond)
Singh DK, Dhakal I, Ghimire S, Pandit N, Sharma R, Dulal S.   +5 more
europepmc   +1 more source

Serial proteomic analysis identifies small extracellular vesicle-MASP2 as an early biomarker of chemotherapy response in advanced pancreatic cancer. [PDF]

Transl Oncol
Dey S, Pandya D, Lo T, Narbutas R, Khandpur B, Krumholtz P, Shervinrad M, Sullivan K, August D, Evans S, Nair S, Okby N, Niland G, Frank RC.   +13 more
europepmc   +1 more source

Comparison of second-line chemotherapy regimens in advanced biliary tract cancer: a systematic review, meta-analysis, and population-based cohort study. [PDF]

Int J Surg
Leem G, Kim K, Kim J, Lee HS, Chung MJ, Park JY, Park SW, Kim YH, Bang S.   +8 more
europepmc   +1 more source

Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG). [PDF]

J Clin Med
Kalem A, Kus T, Gokcek S, Unek IT, Sahin TK, Dizdar O, Sagıroglu MF, Bolek H, Urun Y, Yaslıkaya S, Bayram E, Sever N, Bayoğlu IV, Acar O, Erdogan AP, Saray S, Karabuga B, Arslan Yalcıntas U, Efil SC, Sendur MAN, Aykut T, Araz M, Gunes TK, Ozcelik M, Seyyar M, Aktas G, Yalcın S.   +26 more
europepmc   +1 more source

Dabrafenib plus trametinib in an elderly patient with BRAF V600E-mutant advanced pancreatic adenocarcinoma: A case report. [PDF]

Front Oncol
Liu L, Zhu X, Guo Y, Tang M, Zhou W, Chen B.   +5 more
europepmc   +1 more source

Contemporary Adjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasms.

JAMA Netw Open
Lucocq J, Haugk B, White S, Marchegiani G, Holmberg M, Zerbi A, Pagnanelli M, Lu Z, Inoue Y, Choi M, Kang CM, Visser B, Corpelijn L, Andersson B, Bereza-Carlson P, Björnsson B, Wennerblom J, Labori KJ, Goh BKP, Hartman V, Ahmad S, Patel S, Berrevoet F, Mortensen K, Roberts K, Ausania F, Lynch C, Gupta A, Bertrand C, Kleeff J, Addeo P, Bellotti R, Ven Fong Z, Friess H, Koea J, Gomez D, Gordon-Weeks A, Doria C, Tzimas G, Franklin O, Månsson C, Cabús SS, Bhogal RH, Pathak S, Honselmann KC, Balakrishnan A, Harrison E, Mann K, Gill AJ, Mittal A, Samra J, Athwal T, Loveday B, Teh C, Bhardwaj N, Menon K, Thapa P, Matsumoto I, Jamieson N, Rebours V, Descourvieres C, Davidson B, Soreide K, Pandanaboyana S, Adeno-IPMN2 Collaborative.   +64 more
europepmc   +1 more source